Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis

Annals of Allergy, Asthma and Immunology

Volumn 87, Issue 4, 2001, Pages 327-334

  McCarty, James M ^a   Pierce, Phillip F ^b  

^a Hill Top Research Inc   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFPROZIL; CLARITHROMYCIN;

ADULT; ALLERGY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DIARRHEA; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMPHYSEMA; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; STREPTOCOCCUS PNEUMONIAE; TASTE DISORDER;

EID: 0034762274     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62248-X     Document Type: Article

References (28)

1. Infectious exacerbations of chronic bronchitis: Diagnosis and management
2. Chronic bronchitis, asthma, and pulmonary emphysema: A statement by the Committee on Diagnostic Standards for Nontuberculosis Respiratory Diseases
3. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
4. Antibiotics in chronic obstructive pulmonary disease exacerbations
5. Cefprozil vs. cefuroxime axetil in mild to moderate lower respiratory tract infections: A focus on bronchitis
6. A multicenter study of cefprozil vs clarithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis
7. A randomized, multicenter, comparative trial of cefprozil and cefuroxime axetil in the treatment of acute bacterial bronchitis and AECB
8. The macrolides: Erythromycin, clarithromycin, and azithromycin
9. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis
10. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis
11. Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis
12. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy
13. A roundtable discussion of antibiotic resistance: Putting the lessons to work
14. The role of antimicrobial therapy in acute exacerbations of chronic bronchitis
15. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis
16. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis
17. Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis
18. Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis
19. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis
20. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome
21. Clinical efficacy of azithromycin in lower respiratory tract infections
22. Optimizing economic outcomes in antibiotic therapy of patients with acute bacterial exacerbations of chronic bronchitis
23. Parameters important in short antibiotic courses
24. Low dosage and long treatment duration of β-lactam
25. Treatment of acute otitis media with a shortened course of antibiotics: A meta-analysis
26. Pneumococcal macrolide resistance - Myth or reality?